Advice to warn patients about rare side effects overturns accepted practiceBMJ 1996; 313 doi: http://dx.doi.org/10.1136/bmj.313.7071.1554a (Published 14 December 1996) Cite this as: BMJ 1996;313:1554
- James Warner
- Lecturer in psychiatry Royal Free Hospital School of Medicine, University of London, London NW3 2PF
EDITOR,—The Committee on Safety of Medicines recently advised doctors in Britain to warn patients who were being prescribed mefloquine about potential neuropsychiatric side effects, which occur with a frequency of around 1 in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial